Ovarian endometrioid carcinoma and endometriosis developing in a postmenopausal breast cancer patient during tamoxifen therapy: a case report and review of the literature.
We present the first case of ovarian endometrioid carcinoma and endometriosis in a postmenopausal patient who was treated with tamoxifen for breast cancer. The association with prolonged unopposed estrogen-like stimulation with tamoxifen as a possible factor in the development of ovarian endometrioid carcinoma is discussed.
Cohen
I
I
Department of Obstetrics and Gynecology, Sapir Medical Center, Kfar Saba, Israel.
Altaras
M M
MM
Lew
S
S
Tepper
R
R
Beyth
Y
Y
Ben-Baruch
G
G
D000368:Aged; D001943:Breast Neoplasms / Q000188:drug therapy*; D018269:Carcinoma, Endometrioid / Q000139:chemically induced* / Q000473:pathology; D004715:Endometriosis / Q000139:chemically induced* / Q000473:pathology; D005260:Female; D006801:Humans; D016609:Neoplasms, Second Primary / Q000139:chemically induced*; D010051:Ovarian Neoplasms / Q000139:chemically induced* / Q000473:pathology; D017698:Postmenopause; D013629:Tamoxifen / Q000009:adverse effects*
D013629:Tamoxifen